News

Novo Nordisk to Resubmit Rejected Insulin Candidates to FDA
Krystle Vermes
The FDA refused to approve the ultra-long-acting insulin treatments 2 years ago.
Kirk McKay, Managing Editor
Hospital readmissions are a major driver of spending in the Medicare program.
Meghan Ross, Associate Editor
Team-based care and the importance of relationships between pharmacists and physicians were the emphasis of the keynote address at the American Pharmacists Association 2015 annual meeting.
Jeannette Y. Wick, RPh, MBA, FASCP
Diabetes mellitus diagnoses are soaring in numbers, with the elderly population disproportionately affected. The APhA featured a case-based presentation at its 2015 annual meeting in San Diego, CA, that discussed diabetes management’s complexities in older adults.
Jeannette Y. Wick, RPh, MBA, FASCP
With many blockbuster biologics’ patents expiring, pharmacists must educate themselves so they can properly inform patients about the safe and effective use of biosimilars.
Krystle Vermes
Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.
Eileen Oldfield, Associate Editor
The pharmacist’s role as a disease educator is moving to the forefront.
Meghan Ross, Associate Editor
Veterans with post-traumatic stress disorder face greater odds of developing heart failure.

Association News

More than 350 pharmacy advocates from 44 states met with members of Congress during NACDS RxIMPACT Day on Capitol Hill.
The initiative will establish network to learn and share best practices to provide better quality and more efficient care.
As part of the initiative, PAPCC will run print and digital advertising in beltway media outlets over the course of the Congressional calendar.
NABP launched .pharmacy to provide a means for easily identifying safe and legal online pharmacies and related resources.
The first-ever NACDS RxIMPACT key contact award was presented to Shopko’s Ryan Swensen.

Pharmacy Market News

The collaboration aims to educate adults with diabetes about their increased risk for potentially serious health problems, including pneumococcal pneumonia, influenza, and hepatitis B.
Forum provides platform for discussion on current and future care of patients living with Gaucher disease.
Treatment with Genzyme’s Cerdelga® (eliglustat) capsules maintains hematological and organ volume stability in adults with Gaucher disease type 1 previously stabilized with intravenous enzyme replacement therapy.

Strategic Alliance Partner News

$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$